{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T00:39:38Z","timestamp":1709685578777},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,3,5]]},"DOI":"10.7759\/cureus.55589","type":"journal-article","created":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T19:49:29Z","timestamp":1709668169000},"source":"Crossref","is-referenced-by-count":0,"title":["Peri-Operative Outcomes Associated With the Placement of Implantable Cardioverter-Defibrillators in Patients With Sarcoidosis: A Nationwide Database Analysis"],"prefix":"10.7759","author":[{"given":"Shreyas","family":"Singireddy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Edusa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4899-2971-6","article-title":"Sarcoidosis","author":"Scadding JG","year":"2013","unstructured":"Scadding JG, Mitchell DN. Sarcoidosis. Springer, New York, NY; 2013. 10.1007\/978-1-4899-2971-6"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1827.1993.tb01149.x","article-title":"Pathological studies on sarcoidosis autopsy. II. Early change, mode of progression and death pattern","volume":"43","author":"Iwai K","year":"1993","unstructured":"Iwai K, Takemura T, Kitaichi M, Kawabata Y, Matsui Y. Pathological studies on sarcoidosis autopsy. II. Early change, mode of progression and death pattern. Acta Pathol Jpn. 1993, 43:377-85. 10.1111\/j.1440-1827.1993.tb01149.x","journal-title":"Acta Pathol Jpn"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.114.011522","article-title":"Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study","volume":"17","author":"Kandolin R","year":"2015","unstructured":"Kandolin R, Lehtonen J, Airaksinen J, et al.. Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study. Circulation. 2015, 17:624-32. 10.1161\/CIRCULATIONAHA.114.011522","journal-title":"Circulation"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.114.011522.","article-title":"Incidence of sudden cardiac death and life-threatening arrhythmias in clinically manifest cardiac sarcoidosis with and without current indications for an implantable cardioverter defibrillator","volume":"146","author":"Nordenswan H. K.","unstructured":"Nordenswan H. K., P\u00f6yh\u00f6nen P., Lehtonen, et al.. Incidence of sudden cardiac death and life-threatening arrhythmias in clinically manifest cardiac sarcoidosis with and without current indications for an implantable cardioverter defibrillator. Circulation. 146:964-975. 10.1161\/CIRCULATIONAHA.114.011522.","journal-title":"Circulation"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/MCP.0000000000000715","article-title":"Sarcoidosis epidemiology: recent estimates of incidence, prevalence and risk factors","volume":"26","author":"Arkema EV","year":"2020","unstructured":"Arkema EV, Cozier YC. Sarcoidosis epidemiology: recent estimates of incidence, prevalence and risk factors. Curr Opin Pulm Med. 2020, 26:527-34. 10.1097\/MCP.0000000000000715","journal-title":"Curr Opin Pulm Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.08.042","article-title":"Challenges in sardiac and pulmonary sarcoidosis: JACC state-of-the-art review","volume":"76","author":"Trivieri MG","year":"2020","unstructured":"Trivieri MG, Spagnolo P, Birnie D, et al.. Challenges in sardiac and pulmonary sarcoidosis: JACC state-of-the-art review. J Am Coll Cardiol. 2020, 76:1878-1901. 10.1016\/j.jacc.2020.08.042","journal-title":"J Am Coll Cardiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3978\/j.issn.2223-3652.2015.12.13","article-title":"Cardiac sarcoidosis-state of the art review","volume":"6","author":"Hulten E","year":"2016","unstructured":"Hulten E, Aslam S, Osborne M, Abbasi S, Bittencourt MS, Blankstein R. Cardiac sarcoidosis-state of the art review. Cardiovasc Diagn Ther. 2016, 6:50-63. 10.3978\/j.issn.2223-3652.2015.12.13","journal-title":"Cardiovasc Diagn Ther"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2014.03.043","article-title":"HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis","volume":"11","author":"Birnie DH","year":"2014","unstructured":"Birnie DH, Sauer WH, Bogun F, et al.. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm. 2014, 11:1305-23. 10.1016\/j.hrthm.2014.03.043","journal-title":"Heart Rhythm"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.10.054","article-title":"2017 AHA\/ACC\/HRS Guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society","volume":"72","author":"Al-Khatib SM","year":"2018","unstructured":"Al-Khatib SM, Stevenson WG, Ackerman MJ, et al.. 2017 AHA\/ACC\/HRS Guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2018, 72:e91-e220. 10.1016\/j.jacc.2017.10.054","journal-title":"J Am Coll Cardiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.hlc.2018.09.011","article-title":"Current device therapies for sudden cardiac death prevention - the ICD, subcutaneous ICD and wearable ICD","volume":"28","author":"Chieng D","year":"2019","unstructured":"Chieng D, Paul V, Denman R. Current device therapies for sudden cardiac death prevention - the ICD, subcutaneous ICD and wearable ICD. Heart Lung Circ. 2019, 28:65-75. 10.1016\/j.hlc.2018.09.011","journal-title":"Heart Lung Circ"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/eus316","article-title":"Efficacy and safety of implantable cardiac defibrillators for treatment of ventricular arrhythmias in patients with cardiac sarcoidosis","volume":"15","author":"Kron J","year":"2013","unstructured":"Kron J, Sauer W, Schuller J, et al.. Efficacy and safety of implantable cardiac defibrillators for treatment of ventricular arrhythmias in patients with cardiac sarcoidosis. Europace. 2013, 15:347-54. 10.1093\/europace\/eus316","journal-title":"Europace"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.09.022","article-title":"Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis","volume":"63","author":"Blankstein R","year":"2014","unstructured":"Blankstein R, Osborne M, Naya M, et al.. Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis. J Am Coll Cardiol. 2014, 63:329-36. 10.1016\/j.jacc.2013.09.022","journal-title":"J Am Coll Cardiol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2017.04.020","article-title":"Prognostic impact of extent, severity, and heterogeneity of abnormalities on (18)F-FDG PET scans for suspected cardiac sarcoidosis","volume":"11","author":"Sperry BW","year":"2018","unstructured":"Sperry BW, Tamarappoo BK, Oldan JD, et al.. Prognostic impact of extent, severity, and heterogeneity of abnormalities on (18)F-FDG PET scans for suspected cardiac sarcoidosis. JACC Cardiovasc Imaging. 2018, 11:336-45. 10.1016\/j.jcmg.2017.04.020","journal-title":"JACC Cardiovasc Imaging"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.12201","article-title":"Right ventricular involvement and the extent of left ventricular enhancement with magnetic resonance predict adverse outcome in pulmonary sarcoidosis","volume":"5","author":"Smedema JP","year":"2018","unstructured":"Smedema JP, van Geuns RJ, Ector J, Heidbuchel H, Ainslie G, Crijns HJ. Right ventricular involvement and the extent of left ventricular enhancement with magnetic resonance predict adverse outcome in pulmonary sarcoidosis. ESC Heart Fail. 2018, 5:157-71. 10.1002\/ehf2.12201","journal-title":"ESC Heart Fail"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-019-01591-y","article-title":"Right ventricular involvement is an important prognostic factor and risk stratification tool in suspected cardiac sarcoidosis: analysis by cardiac magnetic resonance imaging","volume":"109","author":"Kagioka Y","year":"2020","unstructured":"Kagioka Y, Yasuda M, Okune M, et al.. Right ventricular involvement is an important prognostic factor and risk stratification tool in suspected cardiac sarcoidosis: analysis by cardiac magnetic resonance imaging. Clin Res Cardiol. 2020, 109:988-98. 10.1007\/s00392-019-01591-y","journal-title":"Clin Res Cardiol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2021-320244","article-title":"Enhanced oxidative stress and presence of ventricular aneurysm for risk prediction in cardiac sarcoidosis","volume":"108","author":"Yoshitomi R","year":"2022","unstructured":"Yoshitomi R, Kobayashi S, Yano Y, et al.. Enhanced oxidative stress and presence of ventricular aneurysm for risk prediction in cardiac sarcoidosis. Heart. 2022, 108:429-37. 10.1136\/heartjnl-2021-320244","journal-title":"Heart"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/179677-peri-operative-outcomes-associated-with-the-placement-of-implantable-cardioverter-defibrillators-in-patients-with-sarcoidosis-a-nationwide-database-analysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T19:49:39Z","timestamp":1709668179000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/179677-peri-operative-outcomes-associated-with-the-placement-of-implantable-cardioverter-defibrillators-in-patients-with-sarcoidosis-a-nationwide-database-analysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,5]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.55589","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3,5]]}}}